VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Research and development, 2025
- $3.9B
- YoY, 2025
- +7.7%
- 5-year CAGR
- +16.4%
- 10-year CAGR
- +14.7%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $3.9B | +7.7% |
| 2024 | $3.6B | +14.8% |
| 2023 | $3.2B | +24.5% |
| 2022 | $2.5B | −16.7% |
| 2021 | $3.1B | +66.8% |
| 2020 | $1.8B | +4.3% |
| 2019 | $1.8B | +23.9% |
| 2018 | $1.4B | +6.9% |
| 2017 | $1.3B | +26.4% |
| 2016 | $1.0B | +5.2% |
| 2015 | $996M | +16.4% |
| 2014 | $856M | −3.0% |
| 2013 | $882M | +15.2% |
| 2012 | $766M | +8.2% |
| 2011 | $708M | +11.0% |
| 2010 | $637M | +15.8% |
| 2009 | $550M | +6.5% |
| 2008 | $517M | — |